Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
Abstract Pseudomonas aeruginosa is a formidable pathogen that is responsible for a diverse spectrum of human infectious diseases, resulting in considerable annual mortality rates. Because of biofilm formation and its ability of rapidly acquires of resistance to many antibiotics, P. aeruginosa relate...
Guardado en:
Autores principales: | Feng Yang, Jiang Gu, Liuyang Yang, Chen Gao, Haiming Jing, Ying Wang, Hao Zeng, Quanming Zou, Fenglin Lv, Jinyong Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca5d3ae9b83b4366abc7e80e971eb9cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of a novel mCH3 conjugated anti-PcrV scFv molecule
por: Samira Komijani, et al.
Publicado: (2021) -
Pseudomonas aeruginosa OprF plays a role in resistance to macrophage clearance during acute infection
por: Malika Moussouni, et al.
Publicado: (2021) -
Berberine Derivatives as <i>Pseudomonas aeruginosa</i> MexXY-OprM Inhibitors: Activity and In Silico Insights
por: Giorgia Giorgini, et al.
Publicado: (2021) -
Negative pressure wound therapy decreases mortality in a murine model of burn-wound sepsis involving Pseudomonas aeruginosa infection.
por: Yang Liu, et al.
Publicado: (2014) -
Pseudomonas aeruginosa PcrV Enhances the Nitric Oxide-Mediated Tumoricidal Activity of Tumor-Associated Macrophages via a TLR4/PI3K/AKT/mTOR-Glycolysis-Nitric Oxide Circuit
por: Hua Yu, et al.
Publicado: (2021)